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Abstract: Mucoepidermoid carcinoma is the most common malignant tumor of salivary glands. However, it is a rare entity in larynx. 
Laryngeal cases are frequently misdiagnosed with other malignancies and they are under-reported. So, recognizing the clinical and 
histological features of this tumor is essential. Laryngeal mucoepidermoid carcinoma can arise in supraglottis, glottis and subglottis. 
Generally, it presents as a submucosal mass; therefore, progressive symptoms without any identifiable lesion in laryngoscopy must be 
well considered. The prognosis is somehow dependent on the histological features. In high-grade tumors, recurrence is more common 
and radical surgery with radiotherapy is recommended. In this paper, we provide a thorough literature review on mucoepidermoid 
  carcinoma in the larynx. The most important distinguishing features of mucoepidermoid carcinoma and its two major differential 
diagnoses (squamous cell carcinoma and adenosquamous carcinoma) are clearly stated and pitfalls in true diagnosis of this tumor are 
discussed.
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Introduction
Mucoepidermoid  carcinoma  (MEC)  is  the  most 
  common  malignant  tumor  of  salivary  glands  and 
comprises  approximately  5%  of  all  salivary  gland 
tumors.  Laryngeal  cases  comprise  one  third  of 
malignant laryngeal salivary-type tumors.1   However, 
it  is  a  rare  entity  in  the  larynx  and  is  frequently 
  misdiagnosed as other laryngeal tumors. Therefore, 
recognizing  its  clinical  and  histological  features 
and distinguishing it from other common laryngeal 
malignancies are essential.
Methodology
We  performed  a  thorough  review  of  literature  on 
mucoepidermoid  carcinoma  in  larynx.  The  main 
concepts  in  the  literature  and  reported  cases  are 
summarized.  In  addition,  the  most  distinctive 
  histological and clinical features of mucoepidermoid 
carcinoma  are  clearly  stated  in  Tables  1  and  2, 
respectively. For comparison, histological and clini-
cal  features  of  two  major  differential  diagnoses, 
squamous cell   carcinoma (SCC) and adenosquamous 
carcinoma (ASC), are also presented. Pitfalls in true 
diagnosis of this tumor are also discussed.
clinical Features
Laryngeal mucoepidermoid carcinoma   develops from 
the  reserve  cells  in  excretory  ducts  of  submucosal 
glands2  or  from  squamous  cells  in  the  surface 
epithelium.2  This  tumor  was  first  described  by 
  Arcidiacono and Loineo in 1963, as a rare entity.3 The 
majority of laryngeal cases occur in supraglottis (61%), 
but they have also been described in glottis (26%) and 
subglottis (13%) as well as in hypopharynx (Fig. 1). 
This tendency differs from squamous cell carcinoma of 
larynx, which most frequently affects the glottis.4,5 Ho 
et al argued that this tendency is due to the abundance of 
laryngeal glands, histologically identical to the minor 
salivary glands, in the submucosal region of larynx. 
Mucoepidermoid  carcinoma  of  larynx  originates 
from the intercalated cells which are one part of these 
glands; therefore mucoepidermoid carcinoma is likely 
to develop at supraglottis where the laryngeal glands 
are most frequently distributed.6,7
The infrequency of reports on laryngeal mucoepi-
dermoid carcinoma could be attributable to difficult 
recognition of this tumor type when it occurs out-
side the salivary glands. In addition to the possibility 
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of  sampling  errors,  interpretative  errors  of  tumor 
  specimens have been reported.8
Laryngeal MECs occur in people of all ages (peak 
incidence in the 6th decade) and rare cases have been 
reported in children and adolescents.9,10 This tumor has 
a definite male predominance and has a wide spectrum 
of  clinical  behavior  from  locally  invasive  to  highly 
malignant.11,12 Nearly half of the cases develop cervi-
cal lymph node involvement;10,13,14 and the lungs are the 
most frequent site for distant metastasis.12 An extremely 
rare case of metastatic laryngeal mucoepidermoid car-
cinoma in the temporal bone has also been reported.15
Histopathology
Microscopically, these tumors, similar to mucoepi-
dermoid  carcinomas  in  other  sites,  are  composed 
of varying proportions of mucous, epidermoid, and 
intermediate-type cells.16 Thay are classified as low, 
intermediate, and high grade (Figs. 2–4). In general, 
low-grade tumors are predominantly cystic with few 
mitotic figures and no cellular anaplasia. Intermediate-
grade tumors are usually more solid and have cellular 
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Figure 2. Low-grade mucoepidermoid carcinoma with cystic spaces and 
mucous tumor cells. Short and long white arrows indicate intermediate 
and epidermoid cells, respectively. Black arrow shows mucus cells.
Supraglottis
61%
Epiglottis
False
vocal fold
Glottis 26%
Subglottis
13%
Figure 1. Anatomical distribution of mucoepidermoid carcinoma in the 
larynx.
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anaplasia;  high-grade  tumors  typically  have  solid 
growth, anaplasia, and a high mitotic rate.17
Diagnosis
There are pitfalls not only in early detection but also in 
true histopathologic diagnosis of these lesions. Tumors 
often spread submucosally with an intact surface. As 
a result, primary lesions are not detected by laryngos-
copy and most patients are diagnosed in the advanced 
stages.  Therefore,  progressive  hoarseness  and  dys-
pnea, which indicate glottic involvement, as well as 
stridor and airway obstruction, which imply subglottic 
lesions, should be taken into consideration.18 When a 
laryngeal tumor is detected, its true histological diag-
nosis is essential. SCC and MEC have similar histo-
pathologic features and presence of intermediate and 
mucus cells are the only key for differentiation.19 Since 
they have different prognosis and treatment modali-
ties, this differentiation is important. Low-grade MECs 
have better prognosis in adults than SCCs20 whereas 
high-grade tumors are associated with a lower sur-
vival rate, even lower than the survival rates of SCC.19 
Moreover, many early SCCs of larynx are best treated 
by irradiation whereas MECs are successfully treated 
by surgical excision.21 Despite of all these differences, 
these tumors are vastly misdiagnosed with each other 
histologically.19 Some cases have been reported in the 
literature that were initially diagnosed as SCC but the 
presence of glandular structures in metastatic lymph 
nodes  and  positive  mucicarmine  stain  changed  the 
final diagnosis to MEC. For that reason, some authors 
recommend to apply mucicarmine stain to all mistak-
able cases except for obvious squamous cell carcino-
mas arising from the surface mucosa.22 As well, some 
recent studies have focused on distinctive immuno-
histochemical expression of MUC-type mucin family 
in salivary gland tumors and head and neck SCCs.23 
Distinguishing high-grade MEC and SCC by different 
expressions of Cytokeratins (CKs), especially CK14, 
has also been suggested.24
On the other hand, presentation of tumor in meta-
static lymph nodes could be helpful in establishing 
a  true  diagnosis  in  high  grade  tumors.  Therefore, 
  careful  exploration  of  metastatic  lymph  nodes  for 
cystic   features and mucus cells in any laryngeal tumor 
with diagnosis of SCC is recommended.
Distinguishing ASC from MEC is more difficult. 
A significant number of tumors originally diagnosed as 
high-grade MEC are ASC, which has more aggressive 
behavior and shorter overall survival.25 Chenevert et al 
stated that 22 of 100 alleged MECs in their research 
study were ASC.26 Both neoplasms could be of ductal 
or surface mucosa origin and share some similar cell 
types. Mucoepidermoid  carcinoma  does  not usually 
exhibit anaplastic nuclear features and is not associated 
with carcinoma in situ of the overlying mucosa. ASC, 
in contrast to mucoepidermoid carcinoma has tendency 
to demonstrate intercellular bridges, keratin pearl for-
mation  and  distinct  areas  of  adenocarcinoma.27 The 
main histological and clinical features of MEC, ASC 
and SCC are presented in Tables 1 and 2.
prognosis
The  prognosis  is  somehow  dependent  on  the 
histological  features;  high-grade  tumors  have  a 
higher risk of death than low-grade tumors.28 Pires 
et al reviewed the literature and reported that over-
all 5-year survival rates ranged from 0% to 43% 
for patients with high-grade mucoepidermoid car-
cinomas,  62%  to  92%  for  patients  with  interme-
Figure 3. Intermediate-grade mucoepidermoid carcinoma with few mucus 
cells and prominent population of intermediate and epidermoid cells.
Figure 4. High-grade mucoepidermoid carcinoma with poorly   differentiated, 
irregular nests of tumor cells and very focal mucinous differentiation.
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diate-grade tumors, and 92% to 100% for patients 
with low-grade tumors.29 It has been stated that in 
patients  with  tracheobronchial  MEC,  the  propor-
tion of squamoid cells in tumor histology may be 
an indicator of tumor malignancy and lymph node 
metastases.30 The prognosis is not, however, fully 
dependent  on  the  pathological  features.  Low  to 
intermediate  grade  tumors  may  behave  poorly31; 
even, patients with low-grade MECs have occasion-
ally developed distant metastases at early stages.2,32 
The ability to achieve complete surgical resection 
is one of important prognostic factors and patients 
who do not achieve complete surgical resection will 
have a poor prognosis.12 Clinical studies of patients 
with  head  and  neck  mucoepidermoid  carcinomas 
have also revealed that patients over 56 years of age 
are significantly associated with decreased survival 
rate.2 As a result, considerable note must be taken of 
the clinical course and both histological classifica-
tion and clinical behavior, are essential elements to 
make appropriate therapeutic decisions.2,14
Management
As the main method for therapy, most agree on wide 
excision; however, radiotherapy or conservative surgery 
has been used for low grade tumors.33 The extent of 
excision is comparable to that of squamous cell carcinoma 
and extensive tumors require total laryngectomy.19 The 
necessity  of  radical  neck  dissection  is  controversial 
and is usually performed when lymphadenopathy is 
present;34  however,  it  is  highly  recommended  to  do 
elective dissection for all high-grade tumors.
Radical  surgery  followed  by  radiotherapy  has 
improved  local  control  in  salivary  gland  malignan-
cies.35 In addition, postoperative irradiation for MEC 
patients with positive surgical margin has been reported 
to be effective.36 Since high grade MECs have a high 
incidence of local recurrence (up to 50 percent), post-
operative radiotherapy is recommended in these cases.
Nevertheless, recent studies support the elective neck 
dissection and postoperative radiotherapy not only for 
high-grade tumors but also for low-grade histologies 
with positive margins or extracapsular spread.37
conclusion
Mucoepidermoid carcinoma is a rare entity in the lar-
ynx and is frequently misdiagnosed with other laryn-
geal malignancies especially squamous cell carcinoma 
and adenosquamous carcinoma. Therefore, recognizing 
the distinct clinical and histological features of this 
tumor is essential. Progressive hoarseness and dys-
pnea without any identifiable lesion in laryngoscopy 
may  implicate  a  submucosal  mass  like  mucoepi-
dermoid  carcinoma.  Histological  classification  and 
clinical behavior, are both essential elements to make 
appropriate therapeutic decisions in these tumors. In 
the case of high-grade histologies, recurrence must be 
considered and combination of radical surgery, radi-
cal neck dissection and postoperative radiotherapy is 
recommended.
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